Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Short term Debt (2023 - 2025)

Historic Short term Debt for Q32 Bio (QTTB) over the last 3 years, with Q3 2025 value amounting to $6.2 million.

  • Q32 Bio's Short term Debt rose 30652.32% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 30652.32%. This contributed to the annual value of $3.1 million for FY2024, which is 25273.35% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Short term Debt is $6.2 million, which was up 30652.32% from $6.2 million recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's Short term Debt registered a high of $6.2 million during Q3 2025, and its lowest value of $878000.0 during Q4 2023.
  • Moreover, its 3-year median value for Short term Debt was $3.1 million (2024), whereas its average is $3.7 million.
  • Over the last 5 years, Q32 Bio's Short term Debt had its largest YoY gain of 30652.32% in 2025, and its largest YoY loss of 5097.15% in 2025.
  • Q32 Bio's Short term Debt (Quarter) stood at $878000.0 in 2023, then skyrocketed by 252.73% to $3.1 million in 2024, then surged by 101.23% to $6.2 million in 2025.
  • Its last three reported values are $6.2 million in Q3 2025, $6.2 million for Q2 2025, and $4.7 million during Q1 2025.